EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis.

(1) Background: Glioblastoma multiforme (GBM) is the most common and malignant intracranial tumor in adults. At present, temozolomide (TMZ) is recognized as the preferred chemotherapeutic drug for GBM, but some patients have low sensitivity to TMZ or chemotherapy resistance to TMZ. Our previous study found that GBM patients with EGFRvIII (+) have low sensitivity to TMZ.

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.

Background: Human oligodendroglioma presents as a heterogeneous disease, primarily characterized by the isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion. Therapy development for this tumor is hindered by incomplete knowledge of somatic driving alterations and suboptimal disease classification. We herein aim to identify intrinsic molecular subtypes through integrated analysis of transcriptome, genome and methylome.

Variable morphology of the suprascapular notch: an investigation and quantitative measurements in Chinese population.

Although several morphological variations and classification of the suprascapular notch (SSN) were reported in western populations, little attention has been paid to this anatomic issue in the Chinese population. In this research of SSN morphology in Chinese people, 295 specimens of intact dry Chinese adult scapulas were investigated and measured thoroughly and systematically. Morphological features of SSN variations were observed by visual inspection, and correlation parameters of variability and classification were measured in digital images with image processing software and bones with a vernier caliper, respectively.

[Epigallocatechin gallate induces apoptosis in human hepatocellular carcinoma HepG2 cells via TGF/Smad signaling pathway].

Objective: To investigate the cytotoxic effect of epigallocatechin gallate (EGCG) on human hepatocellular carcinoma cell line HepG2 cells and corresponding changes of TGF-beta1-Smad pathway.

Methods: The cytotoxic effect of EGCG on HepG2 cells was determined by MTT assay. Cell cycle and apoptosis rate were detected by flow cytometry.